The Economics Of Managing Biotechnologies Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of The Economics Of Managing Biotechnologies book. This book definitely worth reading, it is an incredibly well-written.
The Economics of Managing Biotechnologies by T.M. Swanson Pdf
The advent of new biotechnologies implies significant changes in the world, both biologically and industrially. Biologically, these new technologies represent changes on a scale never before witnessed in the context of evolutionary systems. How these systems will respond to these changes is uncertain and potentially very significant. The first part of this volume addresses these issues in a series of chapters considering the manner in which societies might analyse and manage these systemic responses to biotechnological changes. The second part of the volume addresses the industrial issues concerning biotechnologies. One of the primary motivations for these changes is to enhance the appropriability of the value of innovation occurring within the life sciences sectors. Changing to a property rights-based system of biotechnology has implications for the nature of research and development within these sectors, and the diffusion and distribution of its benefits across the globe. Another set of chapters in this volume sets out a framework for considering these important industrial issues. The volume is the outcome of a two-year project on the economics of managing biotechnologies in agriculture. It is recommended to academics and policy makers interested in the issues concerning society's options in the management of this process of technological change.
The Economics of Biotechnology by James D. Gaisford Pdf
'The book does an excellent job at addressing all three levels from an efficiency and equity point of view . . . Readers with a background in biotechnology but less knowledge in economics will find it very useful, as well as economists who are interested in the key economic issues of biotechnology . . . I agree with the publisher that the addressed audience will welcome and like the book, and I can highly recommend it.' - Justus Wesseler, European Review of Agricultural Economics 'The book is an absorbing one . . . will give insight on business of biotechnology and related issues, such as ethical issues, IPR etc and to economist and market researchers with specified interest in biotechnology. This could be also useful for international policymakers/planners and economic commentators.' - Ashok Pandey, Journal of Scientific and Industrial Research The Economics of Biotechnology is a highly accessible book dealing with some of the most crucial issues to arise in this area. Special attention is paid to consumer, ethical and environmental concerns as well as questions relating to trade policy, intellectual property, who will receive the benefits, international development and the role of international institutions such as the WTO. The authors examine concerns arising from the application of biotechnology in the agri-food industrial complex, and many of the issues discussed also have implications for the medical and pharmaceutical aspects of biotechnology.
The Economic Dynamics of Modern Biotechnology by Maureen D. McKelvey,Annika Rickne,Jens Laage-Hellman Pdf
A highly ambitious work, this book attempts to examine modern biotechnology as an economic process and, in so doing, draws heavily upon the conceptual framework of evolutionary economics and the literature on industrial management. The empirical focus is on the present-day European scene.
The Economics of Biotech Quality Enhanced Crops by Nicholas Kalaitzandonakes,Alex Magnier Pdf
This book presents a framework for analyzing the economics of quality-enhanced biotech crops from concept to commercial introduction and use, focusing on how their economic value and supply chains must be modified. The book introduces systematic ways for analyzing key aspects of commercialization, including estimating potential demand; potential substitution with existing products in the market; potential production systems and supply; potential supply chains and their economics; potential premiums that must be paid by users; and potential premiums that may be paid to the supply chain as well as to producers and others. It outlines methods, models and data that may be used for such analysis and will demonstrate their use through empirical applications in the context of HOS. It is accessible and valuable to a broad audience including policy-makers, regulators, economists, lawyers, industry executives, and scientists with an interest in the commercialization and impact of all emerging genetically modified crops with enhanced quality traits. Key Features * Analytical framework for looking at quality-enhanced crops * Detailed assessment of first major quality-enhanced crop * Considers the economic value and supply chains
Regulating Agricultural Biotechnology by Richard E. Just,Julian M. Alston,David Zilberman Pdf
This book presents the first thorough economic analysis of current agricultural biotechnology regulation. The contributors, most of whom are agricultural economists working either in universities or NGOs, address issues such as commercial pesticides, the costs of approving new products, liability, benefits, consumer acceptance, regulation and its impacts, transgenic crops, social welfare implications, and biosafety.
The Economic and Environmental Impacts of Agbiotech by Nicholas Kalaitzandonakes Pdf
After almost fifteen years in the laboratory and in the test plots, bioengineered crops arrived to the market in the mid-1990s. Adoption was rapid and wide spread. In 1996, less than 4 million acres in six countries were planted with bioengineered crops. By 2001, worldwide adoption had expanded to more than 115 million acres. Important questions quickly followed. What were the factors driving the widespread adoption and rapid diffusion of these first-generation agrobiotech nologies? What were their economic and environmental impacts? How were such impacts distributed among large and small producers, innovators and adopters, developed and developing countries, exporters and importers, domestic and foreign consumers? How were such impacts and their distribu tion affected by market structure and government policies? A growing body of literature has provided valuable answers to some of these questions. However, an assessment that accounts for the full range of differences in geography, weather, pests, farm structures, and institutions had not been completed. It brings together leading This book provides just such an assessment. authors from around the world who have analyzed the production, environ mental, and economic impacts of first-generation crop biotechnologies. By pooling experiences across various countries, time periods, crops, and traits, this global panel is able to synthesize a complete picture of the impacts of first-generation crop biotechnologies.
Author : Sarah Giest Publisher : University of Toronto Press Page : 200 pages File Size : 47,7 Mb Release : 2021 Category : POLITICAL SCIENCE ISBN : 9781442622142
"In The Capacity to Innovate, Sarah Giest provides insight into the collaborative and absorptive capacities needed to provide public support to local innovation through cluster organizations. The book offers a detailed view of the vertical, multi-level, and horizontal dynamics in clusters and cluster policy and addresses how they are managed and supported. Using the biotechnology field as an example, Giest highlights challenges in the collaborative efforts of public bodies, private companies, and research institutes to establish a successful eco-system of innovation in this sector. The book argues that cluster policy in collaboration with cluster organizations should focus on absorptive and collaborative capacity elements missing in the cluster context in order to improve performance. Currently, governments operate at different levels--local to supranational--in order to support clusters, and cluster policies are often pursued in parallel to other programs. As the book shows, this can lead to uncoordinated efforts and ineffective cluster strategies. Relational dynamics are often overlooked when working backwards from performance indicators, since their effects are largely indirect but Giest demonstrates that both the cluster organization and the cluster eco-system play a role. The Capacity to Innovate advocates for a coordinated effort by government and cluster organizations to support capacity elements lacking within the specific cluster context."--
Economics and Management in the Biopharmaceutical Industry in the USA by Rachel Kim Pdf
This book presents an overview of the biopharmaceutical industry, putting it in a historical context. It provides readers with a detailed account of the achievements in drug discovery and development and current biopharmaceutical industry issues.
Agricultural Biodiversity and Biotechnology in Economic Development by Joseph Cooper,Leslie Lipper,David Zilberman Pdf
This volume summarizes the current state of knowledge in the economic literature of management of agricultural biotechnology and biodiversity in agricultural and economic development. It identifies key issues confronting policy makers in managing biodiversity and biotechnology and provides a broad, multi-disciplinary analysis of the linkage between the two. It is especially innovative in its use of plant genetic resource management as the basis for is analysis.
Agricultural Biodiversity and Biotechnology in Economic Development by Joseph Cooper,Leslie Lipper,David Zilberman Pdf
This volume summarizes the current state of knowledge in the economic literature of management of agricultural biotechnology and biodiversity in agricultural and economic development. It identifies key issues confronting policy makers in managing biodiversity and biotechnology and provides a broad, multi-disciplinary analysis of the linkage between the two. It is especially innovative in its use of plant genetic resource management as the basis for is analysis.
Managing Biotechnology by Francoise Simon,Glen Giovannetti Pdf
A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE “Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they can–and must–apply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system.” BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM “Simon and Giovannetti have written an essential user’s manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds.” EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB “If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.” JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS “Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to today’s innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book.”
This book is open access under a CC BY 4.0 license. This book defines the new field of "Bioeconomy" as the sustainable and innovative use of biomass and biological knowledge to provide food, feed, industrial products, bioenergy and ecological services. The chapters highlight the importance of bioeconomy-related concepts in public, scientific, and political discourse. Using an interdisciplinary approach, the authors outline the dimensions of the bioeconomy as a means of achieving sustainability. The authors are ideally situated to elaborate on the diverse aspects of the bioeconomy. They have acquired in-depth experience of interdisciplinary research through the university’s focus on “Bioeconomy”, its contribution to the Bioeconomy Research Program of the federal state of Baden-Württemberg, and its participation in the German Bioeconomy Council. With the number of bioeconomy-related projects at European universities rising, this book will provide graduate students and researchers with background information on the bioeconomy. It will familiarize scientific readers with bioeconomy-related terms and give scientific background for economists, agronomists and natural scientists alike.
In her quest for a global leadership in science and technology, the People's Republic of China has attained top ranks in the number of scientific publications, "hot papers," or national and international patent applications. This also pertains to fields such as biomedicine, agricultural and industrial biotechnology, as well as environmental monitoring and sanitation. However, analysis of the underlying structures and mechanisms is hindered by the sheer flood of data, by stringent government control of all media, including the internet; and by ambiguities inherent in translation from Chinese. This book tries to overcome these difficulties and provides a concise picture of the biotechnology-related research and development (R&D) in China. The book begins with brief accounts of China's geography, people, and their mindset; her political and administrational structure, economy, and finance; her infrastructure related to science and technology; and her educational system and R&D landscape. It then presents succinct accounts on structures and developments in biomedicine, diagnostics, agriculture, fermented food, bioindustry, and environmental biotechnology, with reference to government, industry, and academia. It finally attempts to predict next steps in Chinese biotechnology, both for the national agenda and in view of China's ambitious global development strategy, the Belt and Road Initiative.
